Cargando…
Changes in Serum and Urinary Potassium Handling Associated with Renin-Angiotensin-Aldosterone System Inhibitors in Advanced Chronic Kidney Disease Patients
Objective This study aimed to (i) compare the extent of urinary potassium (K(+)) excretion in addition to the changes in serum K(+) concentration: and (ii) clarify the association between changes in serum K(+) concentration, urinary K(+) excretion, and acid-base status with or without renin-angioten...
Autores principales: | Ueda, Yuichiro, Ookawara, Susumu, Miyazawa, Haruhisa, Ito, Kiyonori, Hirai, Keiji, Hoshino, Taro, Morishita, Yoshiyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820673/ https://www.ncbi.nlm.nih.gov/pubmed/31695981 http://dx.doi.org/10.7759/cureus.5561 |
Ejemplares similares
-
Effects and Safety of Linagliptin as an Add-on Therapy in Advanced-Stage Diabetic Nephropathy Patients Taking Renin–Angiotensin–Aldosterone System Blockers
por: Ueda, Yuichiro, et al.
Publicado: (2016) -
Changes in urinary potassium excretion in patients with chronic kidney disease
por: Ueda, Yuichiro, et al.
Publicado: (2016) -
Relationship Between Serum Total Carbon Dioxide Concentration and Bicarbonate Concentration in Patients Undergoing Peritoneal Dialysis
por: Hirai, Keiji, et al.
Publicado: (2021) -
Approximation of Corrected Calcium Concentrations in Advanced Chronic Kidney Disease Patients with or without Dialysis Therapy
por: Kaku, Yoshio, et al.
Publicado: (2015) -
The Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Advanced-Stage Diabetic Kidney Disease Taking Renin-Angiotensin System Blockers
por: Hirai, Keiji, et al.
Publicado: (2020)